AC Immune SA (ACIU)
NASDAQ: ACIU · IEX Real-Time Price · USD
3.460
-0.020 (-0.57%)
Jul 22, 2024, 10:02 AM EDT - Market open
AC Immune Employees
As of December 31, 2023, AC Immune had 161 total employees, including 133 full-time and 28 part-time employees. The number of employees increased by 5 or 3.21% compared to the previous year.
Employees
161
Change (1Y)
5
Growth (1Y)
3.21%
Revenue / Employee
$104,468
Profits / Employee
-$385,248
Market Cap
346.20M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ModivCare | 21,200 |
Nevro | 1,215 |
Talkspace | 472 |
Kamada | 378 |
Xeris Biopharma Holdings | 377 |
ADC Therapeutics | 274 |
Vanda Pharmaceuticals | 203 |
Cabaletta Bio | 103 |
ACIU News
- 7 weeks ago - AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024 - GlobeNewsWire
- 2 months ago - Alzheimer's vaccine licensing deal boosts AC Immune - Market Watch
- 2 months ago - AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 2 months ago - AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease - Business Wire
- 4 months ago - AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 5 months ago - AC Immune Announces Upcoming Presentations at AD/PD™ 2024 - GlobeNewsWire
- 6 months ago - AC Immune to Regain Global Rights to Crenezumab and Semorinemab - GlobeNewsWire
- 7 months ago - AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases - GlobeNewsWire